Back pain: Ccn2a protein reversed Intervertebral disc (IVD) degeneration in animal model

In a recent in-vivo study on Zebrafish, researchers successfully induced disc regeneration in a degenerated disc by activating an endogenous Ccn2a-FGFR1-SHH signalling cascade. This suggests that Ccn2a protein could be exploited in promotion of IVD regeneration for treatment of backpain.  

Back pain is a common health problem. It is one of the most common reasons for people to seek appointment with doctors. The condition is mainly due to degeneration of intervertebral disc (IVD) which occurs naturally due to wear and tear or ageing. Analgesics and anti-inflammatories along with physiotherapy are currently used to treat the symptoms. In severe cases, disc replacement or disc fusion surgery may be resorted. As such, there is no cure. No known medical treatment or procedure is helpful in restoring disc homeostasis. The solution to the problem lies in finding a way to supress the disc degeneration and/or to induce disc regeneration.  

In an in-vivo study on Zebrafish, reported on 6th January 2023, the researchers discovered that Cellular communication network factor 2a (Ccn2a), a protein secreted by the cells of the intervertebral disc induces disc regeneration in old degenerated discs by promoting cell proliferation and cell survival by modulation of the FGFR1-SHH (Fibroblast growth factor receptor-Sonic Hedgehog) pathway.  

Apparently, this is for the first time that disc regeneration in a degenerated disc has been induced in vivo by activating an endogenous signalling cascade.  

This development may be a steppingstone towards designing a novel strategy to suppress disc degeneration or induce disc regeneration in degenerated human discs.  

*** 

References:  

Rayrikar A.Y., et al 2023. Ccn2a-FGFR1-SHH signaling is necessary for intervertebral disc homeostasis and regeneration in adult zebrafish. Development. Volume 150, Issue 1. Published 06 January 2023. DOI: https://doi.org/10.1242/dev.201036 

*** 

Latest

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Newsletter

Don't miss

Progress in Antiproton Transportation  

Big Bang produced equal amounts of matter and antimatter...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Sugars and Artificial Sweeteners Harmful in the Same Manner

Recent studies have shown that artificial sweeteners need to...

Gluten Intolerance: A Promising Step Towards Developing a Treatment for Cystic Fibrosis and Celiac Disease

Study suggests a new protein involved in development of...

Gravitational-wave Background (GWB): A Breakthrough in Direct Detection

Gravitational wave was directly detected for the first time in...

IGF-1: Trade Off Between Cognitive Function and Cancer Risk

Insulin-like growth factor 1 (IGF-1) is a prominent growth...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as indicated by Villabruna specimen from Late Upper Palaeolithic era. A recent study on 59,000-year-old Neanderthal...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...